ALFA Finder| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 110.6 | 90.1 | 87.1 |
| Other income | 0.6 | 1.9 | 0.5 |
| Total income | 111.2 | 91.9 | 87.7 |
| Profit before exceptional items & tax | 13.1 | 10.1 | 8.0 |
| Profit before tax | 13.1 | 10.1 | 8.0 |
| Net profit | 9.8 | 7.3 | 6.0 |
| Operating margin | 11.8% | 11.0% | 9.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +63.30% |
|---|---|
| Net profit, quarter on quarter | +34.20% |
| Revenue, year on year | +27.00% |
NSE results filing, NSE: SATKARTAR. Figures extracted from the filing.
Sat Kartar Life Ltd: key numbers
- Share price
- ₹170.90
- Market cap
- ₹269.9 Cr
- Revenue (annual)
- ₹200.7 Cr
- Net profit (annual)
- ₹17.10 Cr
- P/E (TTM)
- 15.8×Sector 43.8×
- Promoter holding
- 63.49%
- FII holding
- 0.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sat Kartar Life Ltd
All →Sat Kartar Life Capacity Expansion: ₹1.25 Cr Investment
Sat Kartar Life proposes a 30-bed Ayurveda hospital in Jaipur at an estimated ₹1.25 Crore investment. The facility is expected to be operational by March 2027.
- Value
- ₹1.25 Cr
- Ayurveda hospital beds
- 30 beds
Sat Kartar Life Convertible Warrants
Sat Kartar Life received NSE in-principle approval to list 5,50,000 equity shares from warrant conversion. Approval is subject to listing application and allottee undertakings.
Sat Kartar Life Capacity Expansion: ₹1 Cr Investment
Sat Kartar Life proposes a 25-bed Ayurveda hospital-cum-therapy centre in Lucknow at ₹1 Crore investment. Expected operational by February 2027 as part of its healthcare network expansion.
- Value
- ₹1.00 Cr
- Execution
- Expected operational by February 2027
- hospital beds
- 25 beds
Sat Kartar Life Earnings Call Transcript: Key Takeaways
Sat Kartar Life is pivoting from pure Ayurveda products to an integrated healthcare model, showing strong revenue growth but scaling back prior top-line guidance to prioritize margins.
- Call
- Guides 32% growth
Sat Kartar Life H1 FY27 Results: Net Profit ₹9.2 Cr, Up 26.0% YoY
Sat Kartar Life Ltd reported revenue from operations of ₹113.9 Cr (+26.4% YoY) and net profit of ₹9.2 Cr (+26.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹9.2 Cr · +26.0% YoY
Sat Kartar Life Investor Presentation: Key Takeaways
H1 FY27 deck discloses no revenue, PAT or EBITDA figures. Balance sheet is debt-free with ₹18.7 Cr net cash. Growth is hospital-led: 30-bed Delhi unit at breakeven, 300 beds targeted by FY27-end.